Related Experiment Videos

Comparison of pulmonary inflammatory mediators in preterm infants treated with intermittent positive pressure

U Thome1, B Götze-Speer, C P Speer

  • 1Department of Pediatrics, University of Ulm, Germany.

Pediatric Research
|September 4, 1998
PubMed

Insights

High frequency oscillatory ventilation (HFOV) did not reduce inflammatory markers in preterm infants compared to intermittent positive pressure ventilation (IPPV). This study found no significant differences in albumin, IL-8, or LTB4 levels between the two ventilation methods.

Area of Science:

  • Neonatal Medicine
  • Pediatric Respiratory Medicine
  • Critical Care

Background:

  • Preterm infants on mechanical ventilation are at risk for bronchopulmonary dysplasia due to increased inflammatory mediators.
  • High frequency oscillatory ventilation (HFOV) is hypothesized to be less traumatic than intermittent positive pressure ventilation (IPPV), potentially reducing inflammation.

Purpose of the Study:

  • To compare the inflammatory response in tracheal aspirates of preterm infants ventilated with HFOV versus a high-rate, low-pressure IPPV.

Main Methods:

  • Seventy-six preterm infants requiring mechanical ventilation were randomized to either IPPV or HFOV within 1 hour of intubation.
  • Tracheal aspirates were collected for 10 days and analyzed for albumin, IL-8, and leukotriene B4 (LTB4), normalized to secretory component for IgA.
  • Bacterially colonized samples were excluded from analysis.

Main Results:

  • Median concentrations of albumin, IL-8, and LTB4 in tracheal aspirates were measured on days 1, 3, 5, 7, and 10.
  • No significant differences in albumin, IL-8, or LTB4 levels were observed between the IPPV and HFOV groups throughout the study period.

Conclusions:

  • High frequency oscillatory ventilation (HFOV) does not appear to reduce the measured inflammatory markers (albumin, IL-8, LTB4) in tracheal aspirates of ventilated preterm infants compared to high-rate, low-pressure IPPV.
  • Further research may be needed to explore other ventilation strategies or adjunctive therapies for reducing inflammation in this vulnerable population.

Related Concept Videos